Heterometallic platinum(II) compounds with ß-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.

A new family of heterometallic compounds 3-6 containing ferrocenyl and platinum(II) centers has been synthesized by reaction of 1-ß-aminoethylferrocene (1) and 1,1'-bis(ß-aminoethyl)ferrocene (2) with Pt(II) precursors. Using K(2)[PtCl(4)] as the Pt(II) source, the cis-square-planar neutral compounds [Fe{η(5)-C(5)H(4)(CH(2))(2)NH(2)}(2)PtCl(2)] (3) and [{Fe(η(5)-C(5)H(4)(CH(2))(2)NH(2))(η(5)-C(5)H(5))}(2)PtCl(2)] (5) were obtained. Reaction of cis-[PtCl(2)(dmso)(2)] with 1 and 2 resulted in the displacement of dmso and chloride ligands from the platinum coordination sphere, affording the cationic and neutral compounds [Fe{η(5)-C(5)H(4)(CH(2))(2)NH(2)}(2)Pt(dmso)Cl]Cl (4) and [Fe(η(5)-C(5)H(4)(CH(2))(2)NH(2))(η(5)-C(5)H(5))Pt(dmso)Cl(2)] (6). Compounds 3-6 were thoroughly characterized using multinuclear ((1)H, (13)C, (195)Pt) NMR, IR spectroscopy, ESI mass spectrometry and elemental analysis. Single-crystal X-ray analysis of heterometallic 6 confirmed the cis geometry of the molecule and revealed that the platinum atom is held in a perfect square-planar geometry. The electrochemical behaviour of the heterometallic compounds 3-6, which has been examined by cyclic (CV) and square wave (SWV) voltammetries in dichloromethane and dmso solution, is characterized by the reversible one-electron oxidation of the ferrocene moieties. The results of the biological activity studies revealed that the organometallic complex 5 is active against all cell lines with GI(50) values in the range 1.7-2.3 µM. When compared to the standard anticancer drug cisplatin, heterotrimetallic 5, possessing two aminoethylferrocenyl units coordinated to the Pt(II) center, showed a greater activity profile in the colon cancer cell line. Cell cycle studies revealed that the new mixed compound exhibits a mechanism of action different to cisplatin.

Pt(II)-activated coupling of aminoethylferrocene with benzonitrile. A facile access route to a new redox-active bis(ferrocenyl-amidine) anion sensor.

A new heterometallic electroactive compound having the ferrocenyl moiety attached to the platinum atom through an amidine functionality has been prepared via Pt(II)-mediated nucleophilic addition of ß-aminoethylferrocene to a benzonitrile ligand. This neutral receptor shows remarkable electrochemical anion-sensing redox response to H(2)PO(4)(-).

Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.

OBJECTIVE: Tuberculosis (TB) in patients with rheumatoid arthritis (RA) undergoing treatment with anti-tumor necrosis factor (TNF) agents is commonly the result of reactivation of latent TB infection (LTBI); detection and treatment of LTBI is essential before treatment with anti-TNF agents. We reported previously that the tuberculin skin test (TST) is inaccurate for diagnosis of LTBI in patients with RA. Here, we compare the prevalence of LTBI in RA patients and matched controls according to positive TST and QuantiFeron-TB Gold In-Tube version (QFT) results and determine their agreement. METHODS: A cross-sectional study of 101 RA patients and 93 controls was conducted in Lima, Perú, where the prevalence of LTBI in the general population has been estimated to be 68%. Blood was drawn for QFT assay followed by TST using 2-TU of RT 23 purified protein derivative. TST was deemed positive at >or= 5 mm for RA patients and >or= 10 mm for controls. RESULTS: There were no significant differences between RA patients and controls for age, sex, bacillus Calmette-Guérin vaccination, or history of or contact with TB. 88% of patients had active RA disease and 2 (1.9%) patients had indeterminate QFT results. The number of subjects testing positive with the QuantiFeron assay was comparable between patients and controls (44.6% vs 59.1%, respectively), whereas the TST detected significantly less LTBI among RA patients (26.7%) than controls (65.6%). Thus, the rate of LTBI in RA patients represented 75% and 41% of the rate in their controls using QFT or TST, respectively (p = 0.008). Poor agreement between TST and QFT was seen in RA patients, but in controls, good agreement was observed between these tests. CONCLUSION: In a TB-endemic population, the QuantiFeron-TB Gold In-Tube assay seemed to be a more accurate test for detection of LTBI in RA patients compared with the TST, and may potentially improve the targeting of prophylactic therapy before treatment with anti-TNF agents.

Chelating dialkoxide titanium complex: a versatile building block for the construction of heterometallic derivatives.

The heterometallic complex [TiCp*(O(2)Bz)(2)AlMe(2)] (2) has been synthesised by reaction of [TiCp*(O(2)Bz)(OBzOH)] (1) with AlMe(3) (Cp*=eta(5)-C(5)Me(5); Bz=benzyl). Complex 1 reacts with HOTf to yield the cationic derivative [TiCp*(OBzOH)(2)]OTf (3) (HOTf=HSO(3)CF(3)). Compound 3 reacts with [{M(mu-OH)(cod)}(2)] (M=Rh, Ir; cod=cyclooctadiene) to render the early-late heterometallic complexes [TiCp*(O(2)Bz)(2){M(cod)}(2)]OTf (M=Rh (4); Ir (5)). The molecular structure of complex 4 has been established by single-crystal X-ray diffraction studies.

A new titanium building block for early-late heterometallic complexes; preparation of a new tetrameric metallomacrocycle by self assembly.

The new titanium dicarboxylate complex Cp*TiMe(OOC)2py (2) [Cp*=eta5-C5Me5; (OOC)2py = 2,6-pyridinedicarboxylate] has been synthesized. The reaction of complex 2 with water renders [Cp*Ti(OOC)2py]2O (3). The molecular structure of 3 has been studied by X-ray diffraction methods. Complex 2 reacts with isocyanides to yield the respective iminoacyl derivatives Cp*Ti(eta2-MeCNR)(OOC)2py [R=tBu (4), 2,6-dimethylphenyl (xylyl) (5)]. The molecular structure of complex4 has been established by X-ray diffraction. Compound 2 has been employed as a new building block for the preparation of new early-late heterometallic compounds; it reacts with [M(mu-OH)(COD)]2 (M = Rh, Ir) to give the corresponding tetranuclear metallomacrocycle derivatives [Cp*Ti{(OOC)(2)py}(mu-O)M(COD)]2 [M = Rh (6); Ir (7)]. The molecular structure of 6 has been established by X-ray diffraction.

Crystal structures of triazine-3-thione derivatives by reaction with copper and cobalt salts.

The reaction of 5-methoxy-5,6-diphenyl-4,5-dihydro-2H-[1,2,4]triazine-3-thione L1H2OCH3 with copper(II) chloride leads to the formation of an organic molecule L2 containing two triazine rings linked by a new S-S bond. A binuclear copper(II) complex, 1, containing L1 is also isolated. The reaction of L1H2OCH3 with copper(I) chloride yields a hexanuclear cluster of copper(I), 2, in which the copper atoms form a distorted octahedron with the ligand L1 acting as an NS chelate and sulfur bridge, giving to the copper ion a trigonal geometry by one N and two S atoms. In any reaction of the disulfide L2 with metal salts, complexes containing this molecule are isolated. Reactions with copper(I) and copper(II) chloride and nickel(II) and cadmium(II) nitrate produce the S-S bond cleavage, giving complexes containing the triazine L1 behaving as the NS anion, which show spectroscopic characteristics identical with those formed by reaction with L1H2OCH3. However, the reaction with cobalt(II) nitrate gives a low-spin octahedral cobalt(III) complex, in which an asymmetric rupture of the disulfide L2 has been produced, giving an unexpected complex with a new ligand and keeping the S-S bond.

Synthesis and conformational studies on hexa-O-alkyl p-unsubstituted calix[6]arenes.

[structure: see text] In this article we describe the selective O-benzylation of para-unsubstituted calix[6]arene 1 in rings 1 and 4 (2a-c) and the subsequent alkylation of phenol groups with alpha-haloesters (methyl esters 3a, 3c, and 3e; tert-butyl esters 3b, 3d, and 3f) to determine the effect of these groups on their conformational behavior. 2D NMR studies at 188 K reveal that compounds 2a-c, 3b, 3d, and 3f are less flexible, showing a 1,2,3-alternate conformation. The same conformation has been observed in the solid state.

Stabilization of the non-canonical adenine-adeninium base pair by N(7) coordination of Zn(II).

A new zinc (II) compound with 9-ethyladenine (9-EtA) of formula [Zn(9-EtA-N7)Cl(3)](9-EtAH) has been synthesized and characterized by X-ray diffraction. Its X-structure consists of an Zn(II) anionic complex and 9-ethyladeninium as counteranion. The Zn(II) complex shows a distorted tetrahedral geometry in which three Cl and an 9-EtA coordinates through N(7) position are the ligands. An indirect chelation via intramolecular H-bond between N(6)H and an Cl ligand is present in the complex. The network of [Zn(9-EtA-N7)Cl(3)](9-EtAH) shows interesting features. Thus, self-association of coordinated adenine-adeninium takes place by H-bonding of N(6)-H...N(1) and N(6)-H...N(7), leading to a polymeric ribbon-like 1D supramolecular arrangement. Ab initio calculations have been applied in order to study the stability of the adenine-adeninium interaction due to the coordination of the Zn(II) to the N(7) position and to compare experimental and theoretical structural data.

New strategy for the asymmetric synthesis of phenyl ketone cyanohydrins: quaternization of cyanohydrins derived from 2-p-tolylsulfinyl benzaldehyde.

[reaction: see text] Optically pure functionalized cyanohydrins derived from 1-[2-(p-tolylsulfinyl)phenyl] ethanone can be obtained by the reaction of 2-p-tolylsulfinyl benzaldehyde derived cyanohydrins with bases and further treatment with suitable electrophiles. High yields and excellent stereoselectivities (up to de >98%) were obtained for these remote 1,4-asymmetric induction processes controlled by a sulfinyl chiral inductor.

Cryotherapy treatment for cervical intraepithelial neoplasia: women's experiences in Peru.

Our objective was to examine cryotherapy experiences among women who received treatment for cervical intraepithelial neoplasia in a cervical cancer prevention project in rural Peru. The sample consisted of all women receiving cryotherapy during a 4-month period (July through October 2001). Structured interviews were conducted to collect information about the adequacy of information provision, women's satisfaction with cryotherapy, their ability to comply with postcryotherapy recommendations and condom use, their experience with cryotherapy side effects, and their satisfaction with cryotherapy follow-up. Of the 224 women who were interviewed, user satisfaction with cryotherapy treatment was generally good. A few women engaged in sex earlier than 30 days after treatment, primarily due to partner pressure to resume sex and the women's inability to successfully negotiate abstention from sex. These couples were not always able to use condoms. The percentage of women reporting vaginal discharge was within the range of responses reported in other studies. Cryotherapy appears to be acceptable to women in low-resource settings such as Peru.

Structural models for the interaction of Cd(II) with DNA: trans-[Cd(9-RGH-N7)2(H2O)4]2+.

Reactions of Cd(NO(3))(2) with the model nucleobases 9-alkylguanine in water at neutral pH, give the compounds trans-[Cd(9-RGH-N7)(2)(H(2)O)(4)](NO(3))(2)(R=Me, Et), with the 9-alkylguanine ligands bound to the metal cation at the N(7) position. The X-ray structures of both compounds are reported. The six-coordinate Cd(II) complexes consist of a highly regular octahedral geometry in which the two 9-alkylguanine ligands are in a trans position to each other and approximately collinear with the metal cation. In addition, the networks of both compounds show interesting features. Thus, intramolecular H-bonds between O(6) and a coordinated water molecule are present, and self-association of guanines via H-bonding of N(3)-H...N(2) take place, leading to a 1D supramolecular polymeric ribbon. Density functional theory calculations have been applied to both compounds in order to study the stability of N(7) metalated guanine-guanine associations by comparing experimental and theoretical results. The potential relevance with regard to possible Cd(II)-DNA cross-links is briefly discussed.

Multinuclear calixarene synthons with covalently linked aryl-palladium(II) complexes.

New synthetic procedures have been developed for potentially useful metallacalixarene building blocks. The metal sites were covalently connected to calix[n]arenes (n = 4, 6) by oxidative addition of 4-iodobenzyl precursors to either Pd(PPh(3))(4) or Pd(2)(dba)(3)/tmeda (dba = dibenzylideneacetone) to furnish calixarene-modified aryl-Pd(II)I(L(n)()) complexes [L(n)() = bis-PPh(3) or N,N,N',N'-tetramethylethylenediamine (tmeda)]. Methods were explored for the selective preparation of mono-Pd(II)-calix[4]arene and di-Pd(II)-calix[n]arenes (n = 4 or 6) complexes and also for bifunctional calix[4]arene synthons with two Pd(II) complexes accompanied by 4-pyridylmethyl or 4-cyanobenzyl groups. The properties of the Pd(II)-calix[n]arenes were studied in detail by one- and two-dimensional NMR and mass spectrometric techniques. The X-ray molecular structures of two 4-iodobenzylcalix[4]arene precursors were also determined.

Versatile chelating behavior of benzil bis(thiosemicarbazone) in zinc, cadmium, and nickel complexes.

Reactions of benzil bis(thiosemicarbazone), LH(6), with M(NO(3))(2).nH(2)O (M = Zn, Cd, and Ni), in the presence of LiOH.H(2)O, show the versatile behavior of this molecule. The structure of the ligand, with the thiosemicarbazone moieties on opposite sides of the carbon backbone, changes to form complexes by acting as a chelating molecule. Complexes of these metal ions with empirical formula [MLH(4)] were obtained, although they show different molecular structures depending on their coordinating preferences. The zinc complex is the first example of a crystalline coordination polymer in which a bis(thiosemicarbazone) acts as bridging ligand, through a nitrogen atom, giving a 1D polymeric structure. The coordination sphere is formed by the imine nitrogen and sulfur atoms, and the remaining position, in a square-based pyramid, is occupied by an amine group of another ligand. The cadmium derivative shows the same geometry around the metal ion but consists of a dinuclear structure with sulfur atoms acting as a bridge between the metal ions. However, in the nickel complex LH(6) acts as a N(2)S(2) ligand yielding a planar structure for the nickel atom. The ligand and its complexes have been characterized by X-ray crystallography, microanalysis, mass spectrometry, IR, (1)H, and (13)C NMR spectroscopies and for the cadmium complex by (113)Cd NMR in solution and in the solid state.

Unexpected single-step formation of 1,2-anti-heterodisubstituted calix[4]arenes upon alkylation of a tribenzoyl precursor.

The selective preparation and complete structural characterization of a small series of 1,2-anti-heterodisubstituted calix[4]arenes has been accomplished. These compounds were obtained in two steps from unsubstituted p-tert-butylcalix[4]arene by tribenzoylation and a subsequent one-pot, two-step sequence involving alkylation with simultaneous partial deacylation, resulting in heterodisubstituted calixarenes carrying an alkyl and an aroyl group. The monoalkyl-tribenzoyl intermediate, prior to in situ deprotection, could also be isolated.

Biopsia de grasa subcutánea para el diagnóstico de amiloidosis secundaria en artritis reumatoide / Subcutaneous fat biopsy to diagnose secondary amyloidosis in patients with rheumatoid arthritis

OBJETIVO: Investigar la presencia de amiloidosis secundaria (AA) en pacientes con diagnóstico de artritis reumatoide (AR). MATERIALES Y MÉTODOS: Se evaluó tiempo de enfermedad (TE), presencia de manifestaciones extraarticulares, capacidad funcional y estadio de progresión anatómica, hemograma, velocidad de sedimentación globular, factor reumatoide (FR) (Test de Látex), albúmina sérica y examen completo de orina. Se realizó aspirado de grasa subcutánea periumbilical. El tejido se coloreó con rojo Congo y observó por microscopía óptica y luz polarizada, siendo positiva la birrefringencia verde manzana. RESULTADOS: Se estudió 81 pacientes con diagnóstico de AR (criterios del ACR), 71 fueron mujeres y 10 varones, con rango de edad 31 a 80 años. 75/81 fueron FR (+), 3/81 AA (+). El TE promedio fue 14,74 años para los AA (-) y 20,3 para los AA (+). Sólo en un paciente se halló amiloide en biopsia renal. CONCLUSIONES: En nuestra serie la frecuencia fue menor a lo reportado. Los pacientes con amiloidosis tuvieron títulos altos de FR y TE más prolongado.

Ciclosporina a dosis bajas en el manejo de la artritis reumatoide / Low dose cyclosporin for rheumatoid arthritis management

El objetivo es evaluar la eficacia y eventual toxicidad de la ciclosponia/A (Cs/A) en el tratamiento de 20 pacientes con el diagnóstico de Artritis Reumatoide (AR), en un seguimiento de 26 semanas con dosis de incio de 3.5 mg/kg/d la que se p;odía incrementar hasta un máximo de 5 mg/kg/d. Se evaluó la eficacia, mediante escala análoga visual de dolor, recuento de articulaciones tumefactas y dolorosas, velocidad de sedimentación globular (VSG), dosaje de p;roteína C reactiva (PCR) y el test de calidad de vida: Health assessment questionaire *HAQ). La toxicidad se registró con la ifnormación clínica y de laboratorio de dcada paciente. Desde la sexta semana de tratgamiento y hasta el final del estudio la Cs-A mejoró en forma significativa el recuento de articulaciones tumefactas (p=0.0410), dolorosas (p=0.0191), ejscala análoga visual del dolor (p=0.0361) y la velocidad de sedimentación globular (p=0.0284). A partir de la decimocuarta semana mejoró el test de HAQ )p=0.0239) y al final del estudio la PCR (p=0.023). La hipertricosis fue la reacción adversa más frecuente (10 pacientes) y en menor cuantía náuseas, bochornos, hipertensión arterial, diarreas, fatiga y temblor de manos. La Cs-A fue eficaz en el control de la enfermedad a partir de la sexta semana de tratamiento en la mayoría de los parámetros. Esta eficacia se mantuvo hasta el final del seguimiento. El efectgo adverso más frecuente fue la hipertricosis. No se registraron reacciones mayores o serias

Tuberculosis pulmonar asociada a la actinomicosis primaria pulmonar / Tuberculosis pulmonary asociated to primary actinomycosis

Presentamos 3 casos de Actinomicosis Primaria Pulmonar, 2 de los cuales estuvieron asociados a Tuberculosis Pulmonar. Un paciente tuvo actinomicosis primaria pulmonar aislada. Se exponen las evidencias clínicas, radiológicas, microbiológicas y terapéuticas. Realizamos una revisión de la literatura correspondiente, haciendo hincapié sobre aspectos patogénicos y diagnósticos de Actinomicosis pulmonar. La casuística corresponde a 1982-86 del HNGAI.